LN 3R70-01; software version 2.6.2 and earlier. The software is used with the Alinity i (LN 03R6...
FDA Device Recall #Z-1580-2020 — Class II — January 24, 2020
Recall Summary
| Recall Number | Z-1580-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 24, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Abbott Gmbh & Co. KG |
| Location | Wiesbaden, N/A |
| Product Type | Devices |
| Quantity | 2676 units |
Product Description
LN 3R70-01; software version 2.6.2 and earlier. The software is used with the Alinity i (LN 03R65-01) processing module and the Alinity c (LN 03R67-01) processing module.
Reason for Recall
Abbott has identified potential performance issues for the Alinity ci -series Software version 2.6.2 and earlier.
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, FL, GA, ID, IL, LA, MA, MD, ME, MI, MN, MC, MS, NC, NJ, NY, OK, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV and countries of Albania, Argentina, Australia, Austria, Bahrain, Bangledesh, Belgium, Bermuda, Bosnia, Botswana, Brazil, Bulgaria, Burkina Faso, Canada, Chile, China, Columbia, Costa Rica, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Madagascar, Malaysia, Mexico, Namibia, Netherlands, New Caledonia, New Zealand, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago Turkey, UEA, UK, Ukraine, Uruguay, Vietnam.
Lot / Code Information
LN 3R70-01; software version 2.6.2 and earlier.
Other Recalls from Abbott Gmbh & Co. KG
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2701-2020 | Class II | Alinity ci series System Control Module (SCM); ... | Jun 19, 2020 |
| Z-2401-2020 | Class II | Alinity C, Processing Module. Chemistry analyz... | May 12, 2020 |
| Z-2117-2020 | Class II | ARCHITECT iGentamicin Reagent Kit - Product Usa... | Apr 24, 2020 |
| Z-1728-2020 | Class II | ARCHITECT HAVAB G Reagent Kit. List Number 6L27... | Mar 9, 2020 |
| Z-0574-2020 | Class II | ARCHITECT HAVAB-G Calibrator, REF 6L27-01 | Nov 7, 2019 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.